iPREFER
Research type
Research Study
Full title
Patient experiences and preference of treatment for Multiple Myeloma
IRAS ID
337372
Contact name
Sally Taylor
Contact email
Sponsor organisation
The Christie NHS Foundation Trust
Duration of Study in the UK
0 years, 6 months, 0 days
Research summary
People can receive many lines of treatment for multiple myeloma. We would like to understand more about the experiences of people being treated for multiple myeloma including what matters most to them when considering treatment options, how their experiences have differed with different treatments and if they have any treatment preferences. Patients at The Christie who have received five or more lines of treatment for Multiple Myeloma will be eligible to take part in this study. They will be asked to participate in an interview which should take approximately 30 minutes to an hour. During the interview they will be asked questions regarding their experiences and preference for treatment. Interviews will be conducted either in person or over the phone depending on patient preference. The interviews will be recorded by the research team using a Dictaphone and transcribed by an external transcription service called 1st Class Secretarial. The transcripts of all participant interviews will be reviewed by members of the research team and experiences will be identified and described.
REC name
North of Scotland Research Ethics Committee 1
REC reference
24/NS/0028
Date of REC Opinion
11 Mar 2024
REC opinion
Favourable Opinion